Related references
Note: Only part of the references are listed.Four familial ALS pedigrees discordant for two SOD1 mutations: are all SOD1 mutations pathogenic?
Ansgar Felbecker et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Mutations of optineurin in amyotrophic lateral sclerosis
Hirofumi Maruyama et al.
NATURE (2010)
Long-term outcome of presymptomatic testing in Huntington disease
Marcela Gargiulo et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2009)
Telephoned BRCA1/2 Genetic Test Results: Prevalence, Practice, and Patient Satisfaction
L. Baumanis et al.
JOURNAL OF GENETIC COUNSELING (2009)
Disclosure of APOE Genotype for Risk of Alzheimer's Disease
Robert C. Green et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6
Caroline Vance et al.
SCIENCE (2009)
Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis
T. J. Kwiatkowski et al.
SCIENCE (2009)
TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology:: a genetic and histopathological analysis
Vivianna M. Van Deerlin et al.
LANCET NEUROLOGY (2008)
Prevalence of SOD1 mutations in the Italian ALS population
A. Chio et al.
NEUROLOGY (2008)
Good practice in the management of amyotrophic lateral sclerosis: Clinical guidelines. An evidence-based review with good practice points. EALSC Working Group
Peter Munch Andersen et al.
AMYOTROPHIC LATERAL SCLEROSIS (2007)
Preventing familial amyotrophic lateral sclerosis: Is a clinical trial feasible?
Michael Benatar et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis
MJ Greenway et al.
NATURE GENETICS (2006)
EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives - An evidence-based review with good practice points
PM Andersen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2005)
Predictive genetic test decisions for Huntington's disease: Elucidating the test/no-test dichotomy
SD Taylor
JOURNAL OF HEALTH PSYCHOLOGY (2005)
Adverse effects of predictive testing for Huntington disease underestimated: Long-term effects 7-10 years after the test
R Timman et al.
HEALTH PSYCHOLOGY (2004)
You have shown me my end: Attitudes toward presymptomatic testing for familial amyotrophic lateral sclerosis
JH Fanos et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2004)
Psychological distress in the 5-year period after predictive testing for Huntington's disease
M Decruyenaere et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2003)
Molecular analysis of the superoxide dismutase 1 gene in spanish patients with sporadic or familial amyotrophic lateral sclerosis
A García-Redondo et al.
MUSCLE & NERVE (2002)